Prof. Osama M. Ibrahim

@tdb2.tanta.edu.eg

Clinical Pharmacy Deptment, Faculty of Pharmacy, Tanta University
Faculty of Pharmacy, Tanta University

Prof. Osama M. Ibrahim


                     Download Compact PDF  
https://researchid.co/osama.mohamed.ibrahim
42

Scopus Publications

245

Scholar Citations

8

Scholar h-index

8

Scholar i10-index

Scopus Publications

  • Adoption of electronic patient medication records in community pharmacies in the United Arab Emirates: A cross-sectional survey
    Ahmad Z Al Meslamani, Anan S. Jarab, Derar H Abdel-Qader, Osama Mohamed Ibrahim, Nadia Al Mazrouei
    Health Information Management Journal, 2025
    Background: Access to accurate and relevant patient health information is crucial for community pharmacists to deliver high-quality care. The use of electronic patient medication records (e-PMR) in the United Arab Emirates (UAE) is currently limited to hospital settings, and community pharmacists do not have access to patient records. Objective: To evaluate the perceptions of community pharmacists regarding the potential benefits, barriers, and concerns associated with the implementation of the e-PMR system in community pharmacies in the UAE. Method: A validated questionnaire was administered to a sample of licensed community pharmacists using proportionate random sampling. The survey was structured and consisted of 40 questions in four sections: characteristics of community pharmacists and pharmacies; perceived usefulness of e-PMR; perceived barriers; and concerns about the use of e-PMR. Results: In total, 552 pharmacists filled out the questionnaire (82.1% response rate). The majority of participants somewhat or strongly agreed that e-PMR would reduce drug abuse (71.6%), dispensing errors (64.4%) and prescribing errors (69.0%), and believed that e-PMR would enhance pharmacists’ ability to perform medication reviews (76.0%). Pharmacists in charge (adjusted odds ratio (AOR) = 2.5; 95% confidence interval (CI): 1.6–3.6), facing difficulty tracking the medical history of patients (AOR = 3.2; 95% CI: 2.8–3.9) and working in pharmacies providing telepharmacy services (AOR = 3.4; 95% CI: 2.7–3.8) were more likely to consider e-PMR useful. Implications: The implementation of the e-PMR system in community pharmacies has potential benefits for patient safety and medication therapy management in the UAE.
  • Lipid and Glucose Profile across Different Mental Disorders
    Derar H. Abdel-Qader, Abdullah Albassam, Esra’ Taybeh, Nadia Al Mazrouei, Sara Murad Albarkat Meer, et al.
    Journal of Clinical Medicine, 2024
    Objectives: Schizophrenia, unipolar depression, bipolar disorder, bipolar mania, and bipolar depression are a few of the severe psychiatric diseases that affect millions of individuals and their overall life quality. This study aimed to look at differences in TGA, TC, HDL, LDL, and FPG levels in people who were going through acute episodes of listed diseases. Materials and methods: A cross-sectional prospective study was carried out in Jordan between January and November of 2023, involving all patients with the aforementioned diseases who attended three psychiatric clinics. This study encompassed results from 1187 patients (women N = 675, 56.87%) who were classified into the following ranges: 65. Results: The average level of LDL was the highest in bipolar depression (112.442 ± 36.178 mg/dL) and the lowest in bipolar mania (111.25 ± 33.14 mg/dL). The average level of HDL was the highest in schizophrenia (58.755 ± 16.198 mg/dL) and the lowest in bipolar depression (45.584 ± 12.128 mg/dL). Both average levels of TC and TGA were the highest in patients with bipolar depression (188.403 ± 37.396 mg/dL and 149.685 ± 96.951 mg/dL, respectively) and the lowest in bipolar mania (164.790 ± 40.488 mg/dL and 100.679 ± 54.337 mg/dL, respectively). The average level of FPG was the highest in unipolar depression (94.00 ± 21.453 mg/dL) and the lowest in bipolar mania (89.492 ± 14.700 mg/dL). Conclusions: The results confirmed that lipid and glucose abnormalities were more common in people with schizophrenia and mood disorders (unipolar and bipolar).
  • Role of telepharmacy in pharmacist counselling to coronavirus disease 2019 patients and medication dispensing errors
    Osama M Ibrahim, Rana M Ibrahim, Ahmad Z Al Meslamani, Nadia Al Mazrouei
    Journal of Telemedicine and Telecare, 2023
    Introduction Remote pharmacist interventions have achieved much more attention during the coronavirus disease 2019 (COVID-19) outbreak, since they reduce the risk of transmission and can potentially increase the access of vulnerable populations, such as patients with COVID-19, to pharmaceutical care. This study aimed to examine differences in rates and types of pharmacist interventions related to COVID-19 and medication dispensing errors (MDEs) across community pharmacies with and without telepharmacy services. Methods This was a prospective, disguised, observational study conducted over four months (from March 2020 to July 2020) in 52 community pharmacies (26 with and 26 without telepharmacy) across all seven states of the United Arab Emirates using proportionate random sampling. A standardised data-collection form was developed to include information about patient status, pharmacist interventions and MDEs. Results The test (telepharmacy) group pharmacies provided pharmaceutical care to 19,974 patients, of whom 6371 (31.90%) and 1213 (6.07%) were probable and confirmed cases of COVID-19, respectively. The control group pharmacies provided care to 9151 patients, of whom 1074 (11.74%) and 33 (0.36%) were probable and confirmed cases of COVID-19, respectively. Rates of MDEs and their subcategories, prescription-related errors and pharmacist counselling errors across pharmacies with telepharmacy versus those without remote services were 15.81% versus 19.43% ( p < 0.05), 5.38% versus 10.08% ( p < 0.05) and 10.42% versus 9.35% ( p > 0.05), respectively. Discussion This is one of the first studies to provide high-quality evidence of the impact of telepharmacy on COVID-19 patients’ access to pharmaceutical care and on medication dispensing safety.
  • Pharmacokinetic interaction of voriconazole and clarithromycin in Pakistani healthy male volunteers: a single dose, randomized, crossover, open-label study
    Mehwish Mushtaq, Kshaf Fatima, Aneeqa Ahmad, Osama Mohamed Ibrahim, Muhammad Faheem, et al.
    Frontiers in Pharmacology, 2023
    Background: Voriconazole an antifungal drug, has a potential for drug-drug interactions (DDIs) with administered drugs. Clarithromycin is a Cytochromes P450 CYP (3A4 and 2C19) enzyme inhibitor, and voriconazole is a substrate and inhibitor of these two enzymes. Being a substrate of the same enzyme for metabolism and transport, the chemical nature and pKa of both interacting drugs make these drugs better candidates for potential pharmacokinetic drug-drug interactions (PK-DDIs). This study aimed to evaluate the effect of clarithromycin on the pharmacokinetic profile of voriconazole in healthy volunteers.Methods: A single oral dose, open-label, randomized, crossover study was designed for assessing PK-DDI in healthy volunteers, consisting of 2 weeks washout period. Voriconazole, either alone (2 mg × 200 mg, tablet, P/O) or along with clarithromycin (voriconazole 2 mg × 200 mg, tablet + clarithromycin 500 mg, tablet, P/O), was administered to enrolled volunteers in two sequences. The blood samples (approximately 3 cc) were collected from volunteers for up to 24 h. Plasma concentrations of voriconazole were analyzed by an isocratic, reversed-phase high-performance-liquid chromatography ultraviolet-visible detector (RP HPLC UV-Vis) and a non-compartmental method.Results: In the present study, when voriconazole was administered with clarithromycin versus administered alone, a significant increase in peak plasma concentration (Cmax) of voriconazole by 52% (geometric mean ratio GMR: 1.52; 90% CI 1.04, 1.55; p = 0.000) was observed. Similarly, the area under the curve from time zero to infinity (AUC0-∞) and the area under the concentration-time curve from time zero to time-t (AUC0-t) of voriconazole also significantly increased by 21% (GMR: 1.14; 90% CI 9.09, 10.02; p = 0.013), and 16% (GMR: 1.15; 90% CI 8.08, 10.02; p = 0.007), respectively. In addition, the results also showed a reduction in the apparent volume of distribution (Vd) by 23% (GMR: 0.76; 90% CI 5.00, 6.20; p = 0.051), and apparent clearance (CL) by 13% (GMR: 0.87; 90% CI 41.95, 45.73; p = 0.019) of voriconazole.Conclusion: The alterations in PK parameters of voriconazole after concomitant administration of clarithromycin are of clinical significance. Therefore, adjustments in dosage regimens are warranted. In addition, extreme caution and therapeutic drug monitoring are necessary while co-prescribing both drugs.Clinical Trial Registration:clinicalTrials.gov, Identifier NCT05380245.
  • Investigating the current environmental situation in the Middle East and North Africa (MENA) region during the third wave of COVID-19 pandemic: urban vs. rural context
    Mohamed Abouzid, Dina M. El-Sherif, Yahya Al Naggar, Mohammed M. Alshehri, Shaima Alothman, et al.
    BMC Public Health, 2022
    Background Coronavirus 2019 (COVID-19) pandemic led to a massive global socio-economic tragedy that has impacted the ecosystem. This paper aims to contextualize urban and rural environmental situations during the COVID-19 pandemic in the Middle East and North Africa (MENA) Region. Results An online survey was conducted, 6770 participants were included in the final analysis, and 64% were females. The majority of the participants were urban citizens (74%). Over 50% of the urban residents significantly (p < 0.001) reported a reduction in noise, gathering in tourist areas, and gathering in malls and restaurants. Concerning the pollutants, most urban and rural areas have reported an increase in masks thrown in streets (69.49% vs. 73.22%, resp.; p = 0.003). Plastic bags and hospital waste also increased significantly with the same p-value of < 0.001 in urban areas compared with rural ones. The multifactorial logistic model for urban resident predictors achieved acceptable discrimination (AUROC = 0.633) according to age, crowdedness, noise and few pollutants. Conclusion The COVID-19 pandemic had a beneficial impact on the environment and at the same time, various challenges regarding plastic and medical wastes are rising which requires environmental interventions.
  • The patterns and determinants of telemedicine use during the COVID-19 crisis: A nationwide study
    Ahmad Z. Al Meslamani, Raghad Aldulaymi, Husam El Sharu, Zaid Alwarawrah, Osama Mohamed Ibrahim, et al.
    Journal of the American Pharmacists Association, 2022
  • The impact of telepharmacy on hypertension management in the United Arab Emirates
    Osama Mohamed Ibrahim, Ahmad Z. Al Meslamani, Rana Ibrahim, Rawan Kaloush, Nadia Al Mazrouei
    Pharmacy Practice, 2022
    Objectives: To assess the effectiveness of telepharmacy services delivered by community pharmacies in hypertension management and examine its influence on pharmacists’ ability to identify drug-related problems (DRPs). Methods: This was a 2-arm, randomised, clinical trial conducted among 16 community pharmacies and 239 patients with uncontrolled HTN in the U.A.E over a period of 12 months. The first arm (n=119) received telepharmacy services and the second arm (n=120) received traditional pharmaceutical services. Both arms were followed up to 12 months. Pharmacists self-reported the study outcomes, which primarily were the changes in SBP and DBP from baseline to 12-month meeting. Blood pressure readings were taken at baseline, 3, 6, 9, and 12 months. Other outcomes were the mean knowledge, medication adherence and DRP incidence and types. The frequency and nature of pharmacist interventions in both groups were also reported. Results: The mean SBP and DBP differences were statistically significant across the study groups at 3-, 6-, and 9-month follow-up and 3-, 6-, 9-, 12- month follow-up, respectively. In detail, the mean SBP was reduced from 145.9 mm Hg in the intervention group (IG) and 146.7 mm Hg in the control group (CG) to 124.5, 123.2, 123.5, and 124.9 mm Hg at 3-, 6-, 9-, and 12-month follow-up in the IG and 135.9, 133.8, 133.7, and 132.4 mm Hg at 3-, 6-, 9-, and 12-month follow-up in the CG. The mean DBP was reduced from 84.3 mm Hg in IG and 85.1 mm Hg in CG to 77.6, 76.2, 76.1, and 77.8 mm Hg at 3-, 6-, 9-, and 12-month follow-up in the IG and 82.3, 81.5, 81.5, and 81.9 mm Hg at 3-, 6-, 9-, and 12-month follow-up in the CG. Medication adherence and knowledge of participants in the IG towards hypertension were significantly improved. The DRP incidence and DRPs per patient identified by pharmacists in the intervention and control groups were 2.1% versus 1.0% (p=0.002) and 0.6 versus 0.3 (p=0.001), respectively. The total numbers of pharmacist interventions in the IG and CG were 331 and 196, respectively. The proportions of pharmacist interventions related to patient education, cessation of drug therapy, adjustment of drug dose, and addition of drug therapy across the IG and CG were 27.5% versus 20.9%, 15.4% versus 18.9%, 14.5% versus 14.8%, and 13.9% versus 9.7%, respectively (all with p<0.05). Conclusion: Telepharmacy may have a sustained effect for up to 12 months on blood pressure of patients with hypertension. This intervention also improves pharmacists’ ability to identify and prevent drug-related problems in community setting.
  • Assessment of A new Strategy to Prevent Prescribing Errors Involving COVID-19 Patients in Community Pharmacies
    Derar H. Abdel-Qader, Ahmad Z. Al Meslamani, Abdullah Albassam, Nadia Al Mazrouei, Asma A. El-Shara, et al.
    Hospital Pharmacy, 2022
    Background: Because COVID-19 patients are vulnerable to prescribing errors (PEs) and adverse drug events, designing and implementing a new approach to prevent prescribing errors (PEs) involving COVID-19 patients has become a priority in pharmacotherapy research. Objectives: To investigate whether using WhatsApp to deliver prescribing error (PE)-related clinical scenarios to community pharmacists could enhance their ability to detect PEs and conduct successful pharmaceutical interventions (PIs). Methods: In this study, 110 community pharmacies were recruited from different regions across Jordan and equally allocated to 2 groups. Over the course of 4 weeks, WhatsApp was used to send PEs-related clinical case scenarios to the active group. The second group was controlled with no clinical scenarios. After completion of the 4-week phase, pharmacists from both groups were asked to document PEs in COVID-19 patients and their interventions using a data-collection form. Results: The incidence of PEs in COVID-19 patients documented in the active group (18.54%) was higher than that reported in the control group (3.09%) ( P = .001). Of the 6598 and 968 PIs conducted by participants working in the active and control group pharmacies, 6013 (91.13%) and 651 (67.25%) were accepted, respectively. The proportions of wrong drug (contraindication), wrong drug (unnecessary drug prescribed/no proof of its benefits), and omission of a drug between the active and control groups were 15.30% versus 7.21% ( P = .001), 11.85% versus 6.29% ( P = .03), and 17.78% versus 10.50% (0.01), respectively. Additionally, the proportions of lethal, serious, and significant errors were 0.74% versus 0.35% ( P = .04), 10.52% versus 2.57% (0.002), and 47.88% versus 9.57% (0.001), respectively. Addition of drug therapy interventions (AOR = 0.62; 95% CI, 0.21-0.84) and errors with significant clinical seriousness (AOR = 0.32; 95% CI, 0.16-0.64). Conclusions PEs involving COVID-19 patients in community settings are common and clinically significant. The intervention assessed in this study could be promising for designing a feasible and time-efficient interventional tool to encourage pharmacists’ involvement in identifying and correcting PEs in light of COVID-19.
  • Virtual Coaching Delivered by Pharmacists to Prevent COVID-19 Transmission
    Derar H. Abdel-Qader, Ahmad Z. Al Meslamani, Nadia Al Mazrouei, Asma A. El-Shara, Husam El Sharu, et al.
    Hospital Pharmacy, 2022
    Background: While the role of pharmacists in the current pandemic control has been recognized worldwide, their coaching efforts to improve public’s behaviors that could prevent COVID-19 transmission has been rarely investigated. Objectives: To assess whether pharmacist-based virtual health coaching sessions could increase the proportion of people who practised healthy social behaviors, to test whether this model can increase the public acceptance of COVID-19 vaccines, and to measure whether these behaviors could actually prevent contracting COVID-19. Method: In this randomized controlled trial, adults who matched specific criteria were randomly allocated into 2 arms. The active arm received 12 pharmacist-based virtual coaching sessions delivered via Zoom® over a month. Participants allocated to the control arm received no coaching. At the end of the last coaching session, both groups were asked to complete a structured questionnaire for outcome assessment. Participants in the active group were followed up to 2 weeks after the end of the last coaching session to check if they contracted COVID-19 or not. The SPSS software version 26.0 (IBM Corp., Chicago, IL) was used for statistical analysis. Results: Of the 300 participants who gave consent for participation, 295 completed the study (147 from the active arm and 148 from the control arm). The proportion of those using face masks, avoiding crowds, and willing to be isolated if infected in the active arm was increased from 51.70%, 53.74%, and 59.86% at baseline to 91.83%, 80.27%, and 96.59% at the end of coaching, respectively (all with P &lt; .05). In addition, the proportion of behaviors, such as disinfecting surfaces, not touching the T-zone, and avoid sharing personal belongings with colleagues at work was increased from 36.05%, 27.89%, and 46.93% at baseline to 63.94%, 52.38%, and 87.75% at the end of coaching, respectively (all with P &lt; .05). Avoid touching the T-zone (OR = 0.43; 95% CI, 0.24-0.89) and using disposable tissues (OR = 0.30; 95% CI, 0.18-0.77), each versus using face masks appropriately were more likely to get COVID-19. Conclusion: Pharmacist-based virtual health coaching could be a potential strategy to increase the proportion of behaviors that could curtail the spread of COVID-19.
  • Pharmacists-physicians collaborative intervention to reduce vaccine hesitancy and resistance: A randomized controlled trial
    Derar H. Abdel-Qader, Wail Hayajneh, Abdullah Albassam, Nathir M. Obeidat, Adel M. Belbeisi, et al.
    Vaccine X, 2022
  • A novel educational approach for improving medication-related problems in community pharmacies
    Nadia Al Mazrouei, Rana M. Ibrahim, Ahmad Z. Al Meslamani, Osama Mohamed Ibrahim
    Research in Social and Administrative Pharmacy, 2022
  • Shedding the light on Pharmacists’ roles during COVID-19 global pandemic
    Osama Mohamed Ibrahim, Rana M. Ibrahim, Yousra A. Ibrahim, Eiman A. Madawi, Maryam Y. Al Deri
    Saudi Pharmaceutical Journal, 2022
  • Assessment of a new strategy for catalyzing deprescribing in community pharmacies
    Osama Mohamed Ibrahim, Nadia Al Mazrouei, Ahmad Z. Al Meslamani, Amira B. Kassem, Noha A. El-Bassiouny, et al.
    Journal of the American Pharmacists Association, 2022
  • The patterns of herbal medicine use in the United Arab Emirates; A national study
    Nadia Al Mazrouei, Ahmad Z. Al Meslamani, Rand Alajeel, Ghaid Alghadban, Neda Ansari, et al.
    Pharmacy Practice, 2022
  • Antibiotic prescribing errors generated by the use of an electronic prescribing system in the emergency department: A mixed-method study
    Journal of Pharmacy and Pharmacognosy Research, 2022
  • An emergency plan for management of COVID-19 patients in rural areas
    Ahmad Z. Al Meslamani, Amira B. Kassem, Noha A. El‐Bassiouny, Osama Mohamed Ibrahim
    International Journal of Clinical Practice, 2021
  • The effectiveness of pharmacist-based coaching in improving breast cancer-related health behaviors: A randomized controlled trial
    Osama Mohamed Ibrahim, Noha A. El-Bassiouny, Esraa Abdelhameed Dergham, Nadia Al MAZROUEI, Ahmad Z. Al MESLAMANI, et al.
    Pharmacy Practice, 2021
  • Evaluation of the use and attitudes of pregnant and postpartum women towards medicine utilisation during pregnancy in the United Arab Emirates: A national cross-sectional study
    Osama H. Mohamed Ibrahim, Rana M. Ibrahim, Noor Kifah Al‐Tameemi, Samah Bahy Mohammed Ebaed, Nadia AlMazrouei, et al.
    International Journal of Clinical Practice, 2021
  • The effect of educational interventions on medication dispensing errors: a randomised controlled trial in community pharmacies in Jordan
    Derar H. Abdel-Qader, Ahmad Z. Al Meslamani, Nadia Al Mazrouei, Salim Hamadi, Osama Mohamed Ibrahim
    Drugs and Therapy Perspectives, 2021
  • Evaluation of Telepharmacy Services in Light of COVID-19
    Osama Mohamed Ibrahim, Rana M. Ibrahim, Derar H. Abdel-Qader, Ahmad Z. Al Meslamani, Nadia Al Mazrouei
    Telemedicine and E Health, 2021
  • Antibiotics use and appropriateness in two Jordanian children hospitals: a point prevalence study
    Derar H Abdel-Qader, Najlaa Saadi Ismael, Abdullah Albassam, Asma’ A El-Shara’, Mohammed S Aljamal, et al.
    Journal of Pharmaceutical Health Services Research, 2021
  • Virtual pharmacist interventions on abuse of over-the-counter medications during COVID-19 versus traditional pharmacist interventions
    Nadia Al Mazrouei, Rana M. Ibrahim, Ahmad Z. Al Meslamani, Derar H. Abdel-Qader, Osama Mohamed Ibrahim
    Journal of the American Pharmacists Association, 2021
  • Assessment of inappropriate prescribing of QT interval-prolonging drugs in end-stage renal disease patients in Jordan
    Ahmad Z. Al Meslamani, Dania Abu-Naser, Derar H. Abdel-Qader, Mohammed S. Aljamal, Mohammed A Alsharif, et al.
    Drugs and Therapy Perspectives, 2021
  • The evolving role of community pharmacists during COVID-19 in the UAE; assessing preparedness and knowledge
    Nadia Al Mazrouei, Rana M Ibrahim, Ahmad Z Al Meslamani, Derar H Abdel-Qader, Adel Shaban Sadeq, et al.
    International Journal of Pharmacy Practice, 2021
  • Community pharmacists’ knowledge of and attitudes toward antibiotic use, resistance, and self-medication in Jordan
    Derar H. Abdel-Qader, Abdullah Albassam, Najlaa Saadi Ismael, Asma’ A. El-Shara’, Ahmad Z. Al Meslamani, et al.
    Drugs and Therapy Perspectives, 2021
  • Development of a multivariable model to predict medication non-adherence risk factor for patients with acute coronary syndrome
    Adel Shaban Sadeq, Asim Ahmed Elnour, Amar Mansour Hamrouni, Mohamed A Baraka, Ahmad Z Al Meslamani, et al.
    Journal of Pharmaceutical Health Services Research, 2021
  • Investigating prescribing errors in the emergency department of a large governmental hospital in Jordan
    Derar H Abdel-Qader, Ahmad Z Al Meslamani, Asma' A El-Shara', Najlaa Saadi Ismael, Abdullah Albassam, et al.
    Journal of Pharmaceutical Health Services Research, 2020
  • Dispensing errors in community pharmacies in the united arab emirates: Investigating incidence, types, severity, and causes
    Osama Mohamed Ibrahim, Rana M. Ibrahim, Ahmad Z. Al Meslamani, Nadia Al Mazrouei
    Pharmacy Practice, 2020
  • Challenges associated with mental health management: Barriers and consequences
    Osama H. Mohamed Ibrahim, Rana M. Ibrahim, Noor Kifah Al-Tameemi, Karen Riley
    Saudi Pharmaceutical Journal, 2020
  • Awareness of Antibiotic Use and Resistance in Jordanian Community
    Derar H. Abdel-Qader, Abdullah Albassam, Najlaa Saadi Ismael, Asma’ A. El-Shara’, Aisha Shehri, et al.
    Journal of Primary Care and Community Health, 2020
  • Assessment of treatment-related problems and associated factors among hospitalized patients in the United Arab Emirates: a retrospective study
    Rand Nidal Hussein, Osama Mohamed Ibrahim
    Journal of Pharmaceutical Health Services Research, 2019
  • Early transition towards a computer-based examination system: The perceptions of senior university students in the middle east
    Pharmacy Education, 2019
  • Knowledge of pharmacists on proper use of oral contraceptive pills and missed dose instructions in united arab emirates
    Osama M. Ibrahim, Rand N. Hussein
    Tropical Journal of Pharmaceutical Research, 2017
  • Knowledge, attitude, and prevalence of use of hormone replacement therapy among women in United ARAB Emirates
    Asian Journal of Pharmaceutical and Clinical Research, 2016
  • Community pharmacists' involvement in breast cancer health promotion in United Arab Emirates (UAE)
    Ibrahim
    American Journal of Pharmacology and Toxicology, 2013
  • Evaluation of self-medication among pharmacy students
    Sharif
    American Journal of Pharmacology and Toxicology, 2012
  • Assessment of Egyptian pharmacists' attitude, behaviors, and preferences related to continuing education
    Osama H. Mohamed Ibrahim
    International Journal of Clinical Pharmacy, 2012
  • Antibiotics misuse in different hospital Wards (A pilot study in an Egyptian hospital)
    Asian Journal of Pharmaceutical and Clinical Research, 2012
  • Barriers affecting compliance of patients with chronic diseases: A preliminary study in United Arab Emirates (UAE) population
    Asian Journal of Pharmaceutical and Clinical Research, 2011
  • Intranasal microemulsion of sildenafil citrate: In vitro evaluation and in vivo pharmacokinetic study in rabbits
    Ahmed H. Elshafeey, Ehab R. Bendas, Osama H. Mohamed
    AAPS Pharmscitech, 2009
  • Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: A single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states
    Iman Saad Ahmed, Mona Hassan Aboul-Einien, Osama Hussein Mohamed, Samar Farghali Farid
    European Journal of Pharmaceutical Sciences, 2008
  • Administration of tobramycin in the beginning of the hemodialysis session: A novel intradialytic dosing regimen
    Osama Hussein Kamel Mohamed, Ihab M. Wahba, Suzanne Watnick, Sandra B. Earle, William M. Bennett, et al.
    Clinical Journal of the American Society of Nephrology, 2007

RECENT SCHOLAR PUBLICATIONS

  • Repurposing nitazoxanide in type 2 diabetes mellitus: a randomized controlled trial
    EM Ghonaim, OM Ibrahim, SK Hegazy, WF Farrag, HR Badr
    Endocrine 90 (2), 596-604 , 2025
    2025
    Citations: 1
  • Efficacy and cost-effectiveness comparison of 10-day, 14-day sequential versus 14-day triple therapies for treating Helicobacter pylori infection in Egyptian patients
    NS Farhoud, OM Ibrahim, SE Ezzat
    Journal of clinical gastroenterology 54 (9), 806-812 , 2020
    2020
    Citations: 15
  • Clinical and Economical Study Evaluating the Utility of Some Novel Biomarkers in Chronic Heart Failure Egyptian Patients.
    TMM 33. Nermin Waleed Fhaid, Osama Mohamed Ibrahim, Medhat Mohamed Ashmawy
    Int. J. Pharm. Sci. Rev. Res 54 (2), 37-44 , 2019
    2019
  • The Possible Effectiveness of Theophylline in Preventing Contrast-Induced Nephropathy in Patient Undergoing Cardiac Catheterization
    AE Osama M Ibrahim1, Sahar M EL-Hagger1, Sameh Khalil2
    Inventi Impact - Cardiology & Haematology 2019 (issue 3), 1-6 , 2019
    2019
  • Role of metformin in oxaliplatin-induced peripheral neuropathy in patients with stage III colorectal cancer: randomized, controlled study
    BM El-Fatatry, OM Ibrahim, FZ Hussien, TM Mostafa
    International journal of colorectal disease 33 (12), 1675-1683 , 2018
    2018
    Citations: 61
  • Effect of combination therapy of ezetimibe and atorvastatin on remnant lipoprotein versus double atorvastatin dose in Egyptian diabetic patients
    MM El‐Tamalawy, OM Ibrahim, TM Hassan, AA El‐Barbari
    The Journal of Clinical Pharmacology 58 (1), 34-41 , 2018
    2018
    Citations: 11
  • Role of Commiphora Mol Mol and Doxycycline in Prophylaxis of Spontaneous Bacterial Peritonitis in Egyptians Cirrhotic Patients
    TM Mostafa, OMH Ibrahim, A Gamal, E El-Berri
    Am. J. Biomed. Sci 7 (3), 176-189 , 2015
    2015
    Citations: 1
  • Evaluation of the protective effect of Cystone ® against cisplatin-induced nephrotoxicity in cancer patients, and its influence on cisplatin antitumor activity
    MA El-Ghiaty, OMH Ibrahim, SM Abdou, FZ Hussein
    International urology and nephrology 46 (7), 1367-1373 , 2014
    2014
    Citations: 23
  • Biotechnology in nutrition and food engineering
    O Ibrahim, D Day
    J Nutr Health Food Eng 1 (5), 0026 , 2014
    2014
    Citations: 1
  • Role of pentoxifylline and sparfloxacin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic patients
    TM Mostafa, OM Ibrahim, GAEK Badra, MS Abdallah
    International Scholarly Research Notices 2014 (1), 595213 , 2014
    2014
    Citations: 7
  • Effect of ketoprofen and indomethacin on methotrexate pharmacokinetics in mice plasma and tumor tissues
    YM Elmorsi, SM El-Haggar, OM Ibrahim, MM Mabrouk
    European journal of drug metabolism and pharmacokinetics 38 (1), 27-32 , 2013
    2013
    Citations: 24
  • Lenticule extraction-No-flap surgery for myopia-Technique provides minimally invasive, all-femtosecond laser refractive correction in single ste???-By Cheryl Guttman Krader
    O Ibrahim, W Sekundo
    Ophthalmology Times 37 (1), 1 , 2012
    2012
  • APOPTOSIS AS A THERAPEUTIC STRATEGY FOR ACUTE LYMPHOBLASTIC LEUKEMIA ():
    E Sidhom, OMH Ibrahim, N El-Ashmawy, NM El-Khodary
    Pediatric Blood & Cancer 53 (5), 762-762 , 2009
    2009
  • Proangiogenic Cytokines, Angiogenesis Inhibitor Endostatin and Matrix Metalloproteinase-9 in Non-Hodgkin's Lymphoma
    NE El-Ashmawy, E El-Zamarany, O Ibrahim, M Enaba, M Rowisha
    Egyptian J. Biomed. Sci. 17 , 2005
    2005
  • . Clinical Study Comparing the Use of -Adrenergic Receptor Blockers Carvedilol Versus Atenolol in Pediatric Heart Failure.
    EAH 19. Ibrahim O. M, Abo-Farrag M.E.
    J. Egypt. Soc. Pharmacol. Exp. Ther. 26 , 2005
    2005
  • Effect of Chromium and Lipoic Acid Supplementation on Hyperglycemia, Dyslipidemia, Fibrinolysis and Oxidative Stress in Type 2 Diabetes Mellitus
    DMAR Wageh M. Awara, Osama M. Ibrahim, Hoda A. El-Bahrawy, ُُEbaa El-Sheikh
    The Egyptian Society of Biochemistry and Molecular Biology 22 , 2004
    2004
  • Pentoxifylline, A Phaosphodiestrase Inhibitor, Improves Glucose Homeostasis and Dyslipidemia by Suppressing Tumor Necrosis Factor-Alpha in Type-2 Diabetes.
    WFSR Hoda A. El-Bahrawy, Osama M. Ibrahim
    The Egyptian Journal of Biochemistry and Molecular Biology , 2004
    2004
  • Clinical and biochemical study on the role of free radicals and antioxidants in male infertility
    OM Ibrahim, G AL AZAB, AA Kolkaila, SK Hegazy
    JOURNAL OF PAN-ARAB LEAGUE OF DERMATOLOGISTS 15, 211-217 , 2004
    2004
    Citations: 2
  • The Effect of Hydrosoluble Coenzyme Q10 on Serum Lipoprotein (a) Level in Acute Coronary Diseases Patients
    OMIMT Gber
    Tanta Medical Journal 30 , 2002
    2002
  • Biogenic Amines in Children with Attention deficit Hyperactivity Disorder
    ARMA 12. Farag S.I., Al-Shahawy A.K., Ibrahim O. M.
    . The Journal of Pediatric Club , 2002
    2002

MOST CITED SCHOLAR PUBLICATIONS

  • Role of metformin in oxaliplatin-induced peripheral neuropathy in patients with stage III colorectal cancer: randomized, controlled study
    BM El-Fatatry, OM Ibrahim, FZ Hussien, TM Mostafa
    International journal of colorectal disease 33 (12), 1675-1683 , 2018
    2018
    Citations: 61
  • Outcome of cholesterol screening in a community pharmacy
    OM Ibrahim, PN Catania, MA Mergener, RB Supernaw
    Dicp 24 (9), 817-821 , 1990
    1990
    Citations: 41
  • Effect of ketoprofen and indomethacin on methotrexate pharmacokinetics in mice plasma and tumor tissues
    YM Elmorsi, SM El-Haggar, OM Ibrahim, MM Mabrouk
    European journal of drug metabolism and pharmacokinetics 38 (1), 27-32 , 2013
    2013
    Citations: 24
  • Evaluation of the protective effect of Cystone ® against cisplatin-induced nephrotoxicity in cancer patients, and its influence on cisplatin antitumor activity
    MA El-Ghiaty, OMH Ibrahim, SM Abdou, FZ Hussein
    International urology and nephrology 46 (7), 1367-1373 , 2014
    2014
    Citations: 23
  • Patterns of corneal topography after penetrating keratoplasty
    O Ibrahim, S Bogan, GO Waring
    European journal of ophthalmology 6 (1), 1-5 , 1996
    1996
    Citations: 20
  • Analyzing pharmacy charges using DRGs
    HF Catania, OM Ibrahim, SL Guasco, PN Catania
    American Journal of Hospital Pharmacy 41 (5), 920-923 , 1984
    1984
    Citations: 18
  • Efficacy and cost-effectiveness comparison of 10-day, 14-day sequential versus 14-day triple therapies for treating Helicobacter pylori infection in Egyptian patients
    NS Farhoud, OM Ibrahim, SE Ezzat
    Journal of clinical gastroenterology 54 (9), 806-812 , 2020
    2020
    Citations: 15
  • Effect of combination therapy of ezetimibe and atorvastatin on remnant lipoprotein versus double atorvastatin dose in Egyptian diabetic patients
    MM El‐Tamalawy, OM Ibrahim, TM Hassan, AA El‐Barbari
    The Journal of Clinical Pharmacology 58 (1), 34-41 , 2018
    2018
    Citations: 11
  • Role of pentoxifylline and sparfloxacin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic patients
    TM Mostafa, OM Ibrahim, GAEK Badra, MS Abdallah
    International Scholarly Research Notices 2014 (1), 595213 , 2014
    2014
    Citations: 7
  • Quantification of muscle tissue magnesium and potassium using atomic absorption spectrometry
    KI Al-Khamis, BM Al-Hadiyah, SA Bawazir, OM Ibrahim, MJ Al-Yamani
    Analytical letters 28 (6), 1033-1053 , 1995
    1995
    Citations: 6
  • Warfarin resistance in a patient with prosthetic valve endocarditis treated with cloxacillin
    OM Ibrahim, AK Allam
    Saudi pharm. j, 56-59 , 1996
    1996
    Citations: 5
  • Quantification of erythrocyte magnesium and potassium using atomic absorption spectrophotometry
    KI Al-Khamis, BM Al-Hadiyah, OM Ibrahim, SA Bawazir
    Analytical letters 26 (4), 689-707 , 1993
    1993
    Citations: 4
  • Using DRG data to justify additional clinical pharmacy staff.
    OM Ibrahim, PN Catania, MA Mergener, HF Catania
    Hospital Pharmacy 20 (11), 812-817 , 1985
    1985
    Citations: 4
  • Clinical and biochemical study on the role of free radicals and antioxidants in male infertility
    OM Ibrahim, G AL AZAB, AA Kolkaila, SK Hegazy
    JOURNAL OF PAN-ARAB LEAGUE OF DERMATOLOGISTS 15, 211-217 , 2004
    2004
    Citations: 2
  • Repurposing nitazoxanide in type 2 diabetes mellitus: a randomized controlled trial
    EM Ghonaim, OM Ibrahim, SK Hegazy, WF Farrag, HR Badr
    Endocrine 90 (2), 596-604 , 2025
    2025
    Citations: 1
  • Role of Commiphora Mol Mol and Doxycycline in Prophylaxis of Spontaneous Bacterial Peritonitis in Egyptians Cirrhotic Patients
    TM Mostafa, OMH Ibrahim, A Gamal, E El-Berri
    Am. J. Biomed. Sci 7 (3), 176-189 , 2015
    2015
    Citations: 1
  • Biotechnology in nutrition and food engineering
    O Ibrahim, D Day
    J Nutr Health Food Eng 1 (5), 0026 , 2014
    2014
    Citations: 1
  • Evaluation of clinical pharmacy service impact on therapeutic drug monitoring of digoxin at a teaching hospital
    OM Ibrahim, SA Bawazir, KI Al-Khamis, MJ Al-Yamani, AM Norelddin
    ALEXANDRIA JOURNAL OF PHARMACEUTICAL SCIENCES 11, 85-90 , 1997
    1997
    Citations: 1
  • Clinical and Economical Study Evaluating the Utility of Some Novel Biomarkers in Chronic Heart Failure Egyptian Patients.
    TMM 33. Nermin Waleed Fhaid, Osama Mohamed Ibrahim, Medhat Mohamed Ashmawy
    Int. J. Pharm. Sci. Rev. Res 54 (2), 37-44 , 2019
    2019
  • The Possible Effectiveness of Theophylline in Preventing Contrast-Induced Nephropathy in Patient Undergoing Cardiac Catheterization
    AE Osama M Ibrahim1, Sahar M EL-Hagger1, Sameh Khalil2
    Inventi Impact - Cardiology & Haematology 2019 (issue 3), 1-6 , 2019
    2019